male infertility. male infertility
Conditions
Interventions
Intervention 1: The intervention group one consumed orally 400 mg pentoxifylline and 400 mg L-carnitin twice daily for 3 months. Intervention 2: The intervention group two consumed orally400mg pe
Treatment - Drugs
The intervention group one consumed orally 400 mg pentoxifylline and 400 mg L-carnitin twice daily for 3 months
The intervention group two consumed orally400mg pentoxifylline and placebo twice daily for 3 months
The intervention group three consumed orally400mg L-carnitin and placebo twice daily for 3 months
The control group fourth consumed orally two type placeboes twice daily for 3 months
Sponsors
Medical Sciences University of kerman
Eligibility
Sex/Gender
Male
Age
25 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria :infertile men with Oligoasthenoteratozoospermia;men with age between 25- 40 years old; men without history of medical or surgery for infertility ;men with wives with ages between 20 - 35 years old and or with no known female fertility risk factors . Exclusion criteria:infertile men with Oligoasthenoteratozoospermia with known etiologies.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Spermogram parameters change. Timepoint: after intervention. Method of measurement: spermogram.;Assissted reproductive technic rates. Timepoint: before intervention. Method of measurement: spermogram. | — |
Secondary
| Measure | Time frame |
|---|---|
| Spermogram improving. Timepoint: after 3 months from intervention. Method of measurement: spermogram.;Qualification of Assissted reproductive technic rates. Timepoint: 3 months after intervention. Method of measurement: spermogram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Gholamreza Sepehri
Research Center of kerman Medical Sciences University
Outcome results
None listed